Delta-like protein 4/DLL4 Protein, Human (HEK293)
Based on 1 Customer Validation
Delta-like protein 4 (DLL4) functions as a Notch ligand and activates NOTCH1 and NOTCH4 in the Notch signaling pathway. It regulates angiogenesis by inhibiting endothelial cell proliferation, migration, and angiogenesis. Delta-like protein 4/DLL4 Protein, Human (HEK293) is the recombinant human-derived Delta-like protein 4/DLL4 protein, expressed by HEK293 , with tag free.
- Species: Human
- Source: HEK293
-
Storage:Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Biological Activity
Description
Delta-like protein 4 (DLL4) functions as a Notch ligand and activates NOTCH1 and NOTCH4 in the Notch signaling pathway. It regulates angiogenesis by inhibiting endothelial cell proliferation, migration, and angiogenesis. Delta-like protein 4/DLL4 Protein, Human (HEK293) is the recombinant human-derived Delta-like protein 4/DLL4 protein, expressed by HEK293 , with tag free.
Background
Delta-like protein 4 (DLL4) is a key participant in the Notch signaling pathway, acting as a Notch ligand with functional implications. It specifically activates NOTCH1 and NOTCH4, contributing to the intricate cellular communication within this signaling cascade. Beyond its role in Notch signaling, DLL4 emerges as a crucial regulator of angiogenesis, exerting a negative influence on endothelial cell proliferation, migration, and angiogenic sprouting. The protein's indispensability extends to retinal progenitor proliferation, where it plays a vital role in suppressing rod fates in late retinal progenitors and ensuring the proper generation of diverse retinal cell types. Additionally, during spinal cord neurogenesis, DLL4 inhibits V2a interneuron fate, adding another layer to its multifaceted functions. The molecular interactions involving DLL4 include its engagement with NOTCH4 and NOTCH1, facilitated by specific domains in DLL4 and NOTCH1, respectively.
Verified Bioactivity
Immobilized Human DLL4 at 0.5 μg/mL (100 μL/well) on the plate. Dose response curve for Anti-DLL4 Antibody with the EC50 of < 10 ng/mL determined by ELISA.
MCE Validation Data
-
Purity - SDS-PAGE
Purity - SDS-PAGE
-
Bioactivity - ELISA
Bioactivity - ELISA
Technical Parameters
-
Species Human
-
Source HEK293
-
Tag Tag Free
-
Accession
Q9NR61 (S27-P524)
-
Molecular Construction
-
N-term
-
DLL4 (S27-P524)
Accession # Q9NR61 -
C-term
-
-
Protein Length
Partial Extracellular Domain
-
Synonyms
DLL4; Notch Ligand Delta-2; Delta Like Canonical Notch Ligand 4; Delta-Like Ligand 4; Drosophila Delta Homolog 4; Delta-Like Protein; Delta-Like Protein 4; Notch Ligand DLL4; Delta4; Delta Ligand 4; Delta-Like 4 Homolog (Drosophila); Hdelta2; Delta-Like 4 (Drosophila); Delta 4; Delta-Like 4 Homolog; AOS6; Delta-Like 4 Protein
-
AA Sequence
SGVFQLQLQEFINERGVLASGRPCEPGCRTFFRVCLKHFQAVVSPGPCTFGTVSTPVLGTNSFAVRDDSSGGGRNPLQLPFNFTWPGTFSLIIEAWHAPGDDLRPEALPPDALISKIAIQGSLAVGQNWLLDEQTSTLTRLRYSYRVICSDNYYGDNCSRLCKKRNDHFGHYVCQPDGNLSCLPGWTGEYCQQPICLSGCHEQNGYCSKPAECLCRPGWQGRLCNECIPHNGCRHGTCSTPWQCTCDEGWGGLFCDQDLNYCTHHSPCKNGATCSNSGQRSYTCTCRPGYTGVDCELELSECDSNPCRNGGSCKDQEDGYHCLCPPGYYGLHCEHSTLSCADSPCFNGGSCRERNQGANYACECPPNFTGSNCEKKVDRCTSNPCANGGQCLNRGPSRMCRCRPGFTGTYCELHVSDCARNPCAHGGTCHDLENGLMCTCPAGFSGRRCEVRTSIDACASSPCFNRATCYTDLSTDTFVCNCPYGFVGSRCEFPVGLP
-
Predicted Molecular Mass
54.3 kDa
-
Molecular Weight
Approximately 55-73 kDa, based on SDS-PAGE under reducing conditions, due to the glycosylation.
-
Glycosylation
Yes
-
Purity
≥ 95%, as determined by reducing SDS-PAGE.
Product Properties
Lyophilized powder
1.Lyophilized from a 0.22 μm filtered solution of PBS, 200 mM Arginine, pH 7.4, 8% trehalose.
2.Lyophilized from a 0.22 μm filtered solution of PBS, 200 mM Arginine, pH 7.4.
3.Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.4, 200 mM arginine, 0.2 mM PMSF.
Please refer to the lot-specific COA for specific buffer information.
<1 EU/μg, determined by LAL method.
It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).
Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
Room temperature in continental US; may vary elsewhere.
Documentation
-
Data Sheet (239 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
Handling Instructions (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)